DMARDs, disease modifying antirheumatic drugs

Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment
A S Russell, G V Wallenstein, T Li, M C Martin, R Maclean, B Blaisdell, K Gajria, J C Cole, J-C Becker, P Emery

Annals of the Rheumatic Diseases Feb 2007, 66 (2) 189-194; DOI: 10.1136/ard.2006.057018
Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis
A Finckh, J F Simard, C Gabay, P-A Guerne

Annals of the Rheumatic Diseases Jun 2006, 65 (6) 746-752; DOI: 10.1136/ard.2005.045062
Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study
M E Weinblatt, E C Keystone, D E Furst, A F Kavanaugh, E K Chartash, O G Segurado

Annals of the Rheumatic Diseases Jun 2006, 65 (6) 753-759; DOI: 10.1136/ard.2005.044404
Swedish registers to examine drug safety and clinical issues in RA
J Askling, C M Fored, P Geborek, L T H Jacobsson, R van Vollenhoven, N Feltelius, S Lindblad, L Klareskog

Annals of the Rheumatic Diseases Jun 2006, 65 (6) 707-712; DOI: 10.1136/ard.2005.045872
High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of host autoantibodies and synovial abnormalities
M van Oosterhout, R J Verburg, E W N Levarht, J D Moolenburgh, R M Barge, W E Fibbe, J M van Laar

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1783-1785; DOI: 10.1136/ard.2004.034793
Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis
V P K Nell, K P Machold, T A Stamm, G Eberl, H Heinzl, M Uffmann, J S Smolen, G Steiner

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1731-1736; DOI: 10.1136/ard.2005.035691
Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression
J Rönnelid, M C Wick, J Lampa, S Lindblad, B Nordmark, L Klareskog, R F van Vollenhoven

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1744-1749; DOI: 10.1136/ard.2004.033571
Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis
L Gossec, D van der Heijde, A Melian, D A Krupa, M K James, P F Cavanaugh, A S Reicin, M Dougados

Annals of the Rheumatic Diseases Nov 2005, 64 (11) 1563-1567; DOI: 10.1136/ard.2004.029611
Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study
H Marzo-Ortega, D McGonagle, S Jarrett, G Haugeberg, E Hensor, P O’Connor, A L Tan, P G Conaghan, A Greenstein, P Emery

Annals of the Rheumatic Diseases Nov 2005, 64 (11) 1568-1575; DOI: 10.1136/ard.2004.022582
Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial
G Kobelt, P Lindgren, A Singh, L Klareskog

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1174-1179; DOI: 10.1136/ard.2004.032789

Main menu

DMARDs, disease modifying antirheumatic drugs

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

DMARDs, disease modifying antirheumatic drugs

Pages